CVS Health Corporation (NYSE:CVS) is listed as one of the 13 Most Undervalued Dividend Stocks to Buy According to Wall Street Analysts. UBS raised its price target on CVS to $96 and maintained a Buy rating on the stock. In the third quarter, CVS reported revenues of $102.8 billion, up 7.8% from the previous year.

CVS Health Corporation generated $7.2 billion in cash flow from operations year-to-date and updated its full-year guidance. The company has been paying consistent dividends since 1997, with a quarterly dividend of $0.665 per share and a dividend yield of 3.30% as of October 29. CVS is recognized for its dividend payments.

While CVS presents investment potential, certain AI stocks offer greater upside potential. For an undervalued AI stock benefiting from Trump-era tariffs, check out a free report. CVS may be a good investment, but other AI stocks could offer more significant gains and less risk. Check out our free report for more information.

Read more at Yahoo Finance: UBS Turns More Bullish on CVS Health (CVS) with $96 Price Target